Authors: GABIZON AA

Citation: Aa. Gabizon, LIPOSOME CIRCULATION TIME AND TUMOR TARGETING - IMPLICATIONS FOR CANCER-CHEMOTHERAPY, Advanced drug delivery reviews, 16(2-3), 1995, pp. 285-294

Authors: VEXLER AM MOU X GABIZON AA GORODETSKY R

Citation: Am. Vexler et al., REDUCTION OF THE SYSTEMIC TOXICITY OF CISPLATIN BY INTRAARTERIAL HEPATIC ROUTE ADMINISTRATION FOR LIVER MALIGNANCIES, International journal of cancer, 60(5), 1995, pp. 611-615

Authors: GABIZON AA

Citation: Aa. Gabizon, LIPOSOMAL ANTHRACYCLINES, Hematology/oncology clinics of North America, 8(2), 1994, pp. 431-450

Authors: GABIZON AA BARENHOLZ Y BIALER M

Citation: Aa. Gabizon et al., PROLONGATION OF THE CIRCULATION TIME OF DOXORUBICIN ENCAPSULATED IN LIPOSOMES CONTAINING A POLYETHYLENE GLYCOL-DERIVATIZED PHOSPHOLIPID - PHARMACOKINETIC STUDIES IN RODENTS AND DOGS, Pharmaceutical research, 10(5), 1993, pp. 703-708